Physician

Michael David Ciliberti, M.D.

According to 2025 Medicare claims, Michael Ciliberti, M.D. (NPI: 1295734564) practices allergy/immunology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is CENTER FOR ALLERGY AND ASTHMA CARE, LLC (NPI: 1902988470; TIN: 204912333) and primary practice location at 18104-9147.

Ciliberti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 16,105 HCPCS/CPT codes, and received $363,919 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,409 prescription claims across 236 beneficiaries totaling $451,534 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 17 claims. Open Payments data shows 117 records totaling $2,933. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $37,365 to $363,919. Similarly, Part D prescription costs have risen steadily, from $167,801 to $451,534. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $400 and ending at $762.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	199	2,846	$37,365
2016	205	6,823	$128,382
2017	222	8,358	$167,108
2018	212	10,898	$230,033
2019	238	11,498	$300,895
2020	252	7,567	$116,203
2021	323	11,763	$136,664
2022	324	8,814	$105,485
2023	310	9,534	$134,208
2024	276	16,105	$363,919

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	170	909	$167,801
2016	189	1,104	$252,661
2017	206	1,183	$314,451
2018	206	1,088	$282,257
2019	191	1,120	$317,742
2020	204	1,112	$342,551
2021	247	1,247	$391,619
2022	245	1,415	$421,864
2023	251	1,381	$478,645
2024	236	1,409	$451,534

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$362
2017	N/R	41	$577
2018	N/R	62	$1,028
2019	N/R	34	$611
2020	N/R	N/R	N/R
2021	N/R	24	$71,081
2022	N/R	61	$74,968
2023	N/R	41	$64,111
2024	N/R	17	$59

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	48	49	$104
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	192	$62
94375	Test to measure rate of airflow	74	79	$27
95165	Professional service for preparation and provision of 1 or more antigens	96	3,733	$10
95117	Professional service for multiple injections of allergen	80	1,044	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	1,740	$37,119
Breo Ellipta	Fluticasone/Vilanterol	68	2,520	$31,777
Xolair	Omalizumab	11	308	$29,978
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	34	714	$28,245
Symbicort	Budesonide/Formoterol Fumarate	34	1,860	$13,457

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0570	Nebulizer, with compressor	Y	N/R	17	$59

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$2,933	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael David Ciliberti, M.D.?

Tedicare shows public-source Medicare data for Michael David Ciliberti, M.D. (NPI 1295734564), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael David Ciliberti, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael David Ciliberti, M.D.?

Michael David Ciliberti, M.D. is linked to CENTER FOR ALLERGY AND ASTHMA CARE, LLC (billing NPI 1902988470) in the available physician profile data.

Does Michael David Ciliberti, M.D. have Open Payments data?

Michael David Ciliberti, M.D. has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.